May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Treatment of Acquired Periodic Alternating Nystagmus With Memantine
Author Affiliations & Notes
  • R. J. McLean
    Ophthalmology Group, University of Leicester, Leicester, United Kingdom
  • S. Thomas
    Ophthalmology Group, University of Leicester, Leicester, United Kingdom
  • S. J. Farooq
    Ophthalmology Group, University of Leicester, Leicester, United Kingdom
  • F. A. Proudlock
    Ophthalmology Group, University of Leicester, Leicester, United Kingdom
  • I. Gottlob
    Ophthalmology Group, University of Leicester, Leicester, United Kingdom
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 882. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R. J. McLean, S. Thomas, S. J. Farooq, F. A. Proudlock, I. Gottlob; Treatment of Acquired Periodic Alternating Nystagmus With Memantine. Invest. Ophthalmol. Vis. Sci. 2007;48(13):882.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: To report a patient with acquired periodic alternating nystagmus secondary to sarcoidosis successfully treated with memantine.

Methods:: A 43 year old man had a four year history of acquired horizontal periodic alternating nystagmus (PAN) with oscillopsia secondary to sarcoidosis. Visual acuity (VA) was measured and eye movement recordings were performed with an infra-red eye tracker (Eyelink I, 250 Hz) before and after treatment with 5 mg memantine per day.

Results:: The visual acuity (VA) was 6/36 in the right eye and 6/24 in the left eye during maximum nystagmus amplitude. The duration of the right beating and left beating phases was 105-110 seconds and of the quite phases was 4-5 seconds. During the quiet phase the nystagmus was insignificant. On memantine the patient became significantly less symptomatic. The right visual acuity improved to 6/6 and the left to 6/4 during the entire cycle of PAN. Before treatment the nystagmus reached a maximum intensity of 11.9°/sec (frequency 3.6 Hz and amplitude 3.3°) during right beating periods and 14.0°/sec (frequency 3.5Hz and amplitude 4.0°) during left beating. Again the quiet phases in between were insignificant in terms of nystagmus. After treatment of 5mg of memantine per day the intensity was reduced to a maximum intensity of 0.41°/sec (frequency 1.54 Hz and amplitude 0.26°) during right beating period and 0.54°/sec (frequency 1.28 Hz and amplitude 0.42°) during left beating.

Conclusions:: We showed for the first time that memantine can reduce PAN dramatically (4% of the original amount). Treatment with memantine should be investigated systematically in PAN.

Keywords: nystagmus • eye movements • drug toxicity/drug effects 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×